Cardiovascular protection and blood pressure reduction: a meta-analysis (Q43782892)

26 November 2017

0 references

Cardiovascular protection and blood pressure reduction: a meta-analysis (English)

1 reference

26 November 2017

0 references

1 reference

1

1 reference

26 November 2017

J G Wang

2

1 reference

PubMed ID

11684211

26 November 2017

L Thijs

series ordinal

3

1 reference

PubMed ID

11684211

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

26 November 2017

1 reference

26 November 2017

358

1 reference

26 November 2017

1305-1315

1 reference

26 November 2017

9290

1 reference

Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTEL).

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Implications of small reductions in diastolic blood pressure for primary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Isolated systolic hypertension in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Systolic versus diastolic pressure: paradigm shift or cycle?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Randomised trial of treatment of hypertension in elderly patients in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Treatment of mild hypertension: a five year controlled drug trial. The Oslo study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Shanghai trial of nifedipine in the elderly (STONE)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Effect of antihypertensive treatment on stroke recurrence. Hypertension-Stroke Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Blood pressure reduction in elderly: a randomised controlled trial of methyldopa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Effects of treatment in hypertension. Results of a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Hypotensive therapy in stroke survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Prospective study on the treatment of mild hypertension in the aged

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Antihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60 to 75 years. Report from a double-blind international multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

The Captopril Prevention Project (CAPPP) in hypertension--baseline data and current status

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Update on the systolic hypertension in Europe (Syst-Eur) trial. The Syst-Eur Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Chinese Trial on Isolated Systolic Hypertension in the Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Clinical results of the Verapamil in Hypertension and Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Reactive oxygen species, metalloproteinases, and plaque stability.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

Blood-pressure lowering for the secondary prevention of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906411-X

7 January 2021

10.1016/S0140-6736(01)06411-X

Identifiers

DOI

1 reference

26 November 2017

1 reference

PubMed ID

11684211